Quick Answer
HOOKIPA Pharma Inc. reported Stockholders Equity of $51.21 million for fiscal year 2024.
HOOKIPA Pharma Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $51.21M | -43.0% |
| 2023 | $89.86M | -12.3% |
| 2022 | $102.52M | +14.4% |
| 2021 | $89.59M | -42.6% |
| 2020 | $156.12M | +32.4% |
| 2019 | $117.90M | +295.3% |
| 2018 | -$60.38M | -41.5% |
| 2017 | -$42.66M | -31.4% |
| 2016 | -$32.47M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | $34.08M | -67.4% | -33.5% |
| December 31, 2024 | $51.21M | -43.0% | -28.7% |
| September 30, 2024 | $71.80M | -24.5% | -16.6% |
| June 30, 2024 | $86.06M | -23.4% | -17.7% |
| March 31, 2024 | $104.52M | +25.2% | +16.3% |
| December 31, 2023 | $89.86M | -12.3% | -5.5% |
| September 30, 2023 | $95.05M | -16.1% | -15.4% |
| June 30, 2023 | $112.33M | -14.9% | +34.6% |
- HOOKIPA Pharma Inc. showed a decrease of -43.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2024 period, HOOKIPA Pharma Inc.’s stockholders equity has grown by 257.7% (from -$32.47 million to $51.21 million).
- The most recent figure is from HOOKIPA Pharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: